The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
All very positive lately....S.P. is reacting slowly...long way to go.....keep the the good news flowing....
New order, excellent news and endorsement . These individually aren’t huge but are cumulative…
After reading and hearing all the future expectations by Kromek of CZT imaging crystals & systems over the months and years and its ever expected uptake by the major OEMs in medical imaging solutions, I’m very relieved to hear of the first new CZT Imaging machines being purchased and installed by hospitals recently. Adoption of new tech is nail biting stuff for the poor old share holders.
So - Oxford, Bath, Budapest to my knowledge. A few in France I think now.
Hearing the doctors and managers comments who know how many lives they will benefit, and extra patients they can screen with this Tech. the preventive procedures they can take and all the unnecessary exploratory operations they will save. Its impressive stuff.
The future of medical 3D Colour exact imaging that many (me) think will be adopted in most hospitals now, if you can screen 4 or 5 , times the number of patients in the same time as before, with far less exposure to radiation than and at an affordable cost it’s hard to see this tech not taking off everywhere. (read somewhere est. 10% of the machine unit cost is for the CZT cameras and hardware & peripherals )
Now with the division of Kromek into 2 separate parts just a few months ago and the tight market for CZT, the slide rules must be coming out….the value of the company is surely under priced just on the ‘medical imaging’ front. It could result in an offer for the imaging part of the business at any time.
The Bio Pathogen and the Radiation detection sides of the business being the on top of the cake.
It’s happening now the ‘launch customers’ of very new technology being supplied with the CZT imaging machines we’ve all
been told about for years. I’m sure we’ll hear of the first actual Kromek equipped CZT machine installed soon. Maybe Philips?
https://impact.ref.ac.uk/casestudies/caseStudy.aspx?I'd=11784
hopefully
To clear up any confusion between CdTe & CdZnTe both are often ref to as CZT it appears-
The Brinkman CZT growth facility of 154 furnaces which provides the core of Kromek's detection tech for advanced imaging. (Info Kromek s site)
named after Prof Andy Brinkman I guess
Durham University case studies article -8
The key breakthrough in growing high perfection single crystals was made by Dr John Mullins, a postdoc working with Prof Brinkman in Durham, funded by the BRITE-EURAM grant. He realised that the vapour source and deposition region could be thermally decoupled by using a bent tube rather than a straight tube, so that the growing crystal was not heated directly by the source. The first high quality CdTe crystals were grown using this technique in 1997, and the process was patented in 1998 [P1]. The first results were published in a peer reviewed journal in 1999 [1], with a full description of the growth system in 2000 [2]..
This work culminated in 2007 with the heteroepitaxial growth of the first high perfection wafers of CdTe with good electrical qualities, using GaAs as the substrate [e.g. 3-5]. By 2009 they could scale this up to grow 4 inch diameter crystals of CdTe, and in 2011 succeeded in making similarly large crystals of CdZnTe [6].
CdZnTe =CZT
A rerate is happening,and probably much further to go.This is a very difficult market to read at the moment,that is why it is important to get into the few shares with potential and plenty of upside with little downside.Capital preservation should be on all investors minds at the moment.
Historic share price barriers seem to be around 16p then 21p then 28p IMHO DYOR. Any views on share price barriers in short / medium term and whether we are likely to test them again ?? or will share price remain subdued for some time ?
This is a very risky environment to invest in the market with inflationary and geo political concerns dominating all matters.This is one of the few shares that you could feel confidence in the future.I am looking for similar situations to park my money....does anybody have other good investments that may thrive in this environment,at low price?
Siemens have a subsidiary manufacturing cdte, slightly different tech vs czt.
Not sure someone else taking early market share with a superior product (with a competing element that kmk cannot supply) is a good news story.
With kmk I have learnt to wait for the numbers ( which means cash in the bank not "orders" or "revenue").
The Siemens Photon Counting CT scanner is another step up in my understanding and more advanced than GE's CZT latest design.Skid Kromek don't manufacture the medical scanners they supply the CZT modules, cameras and electronics to the OEMs which are only now being bought and installed in hospital s after years of development it like black and white TV to colour OLED in image clarity, both GE and Siemens have their own supply of CZT and hardware, but the other 6, 7 or more OEMs don't, 3 of them are customers of Kromek's.
They haven't increased their CZT production capacity 5 fold on a whim they're talking with the other OEMs who want to develop similar scanners.
The article says they Oxford university Hospital are the fore runners of an NHS upgrade to these new high spec low dose rapid scan time units.
So kmk are currently "actively designing" and have clearly yet to market a product that someone else (one of the largest health tech companies in the world with a global reach, massive sales and support network) is x years ahead of them. Brilliant.
It’s a pity then that this “similar tech” isn’t KMKs!
Watch "Get to know the world’s first photon-counting CT: NAEOTOM Alpha" on YouTube
https://youtu.be/HqvbOeuBu1I
Siemens first Photon Counting CT scanner being installed at Oxford Hospital this month.
Kromek is actively designing and marketing this similar tech.
https://www.radmagazine.com/uks-first-photon-counting-ct-scanner-at-the-university-of-oxford-to-redefine-diagnostics/
This is rerating from a very low level.....Worth at least 40p...in my opinion......Orders have started to flood in......mark up very high.....Geo political situation having an effect.....
Insider roster
Individual or entity Most-recent transaction Date Shares owned as of transaction date
BARCLAYS WEALTH
Annual Return
30 Jun 2021
13,296,690
BASU (ARNAB)
Annual Return
12 May 2021
2,988,750
HARGREAVE HALE LTD
Annual Return
03 Aug 2021
33,688,423
HARGREAVES LANSDOWN ASSET MANAGEMENT LTD.
Annual Return
03 Aug 2021
34,334,276
HERALD INVESTMENT MANAGEMENT LTD
Annual Return
03 Aug 2021
21,080,059
JARVIS INVESTMENT MANAGEMENT LTD.
Annual Return
30 Jun 2021
11,488,421
LLOYDS BANKING GROUP PLC
Annual Return
03 Aug 2021
17,829,469
NEWLANDS (DAVID JOHN)
Increase
28 Sept 2021
11,725,000
SHARMA (RAKESH)
Bought
16 May 2022
807,539
SPEIRS (GRAEME KENNETH)
Annual Return
03 Aug 2021
20,273,475
Major holdersCurrency in GBp
Breakdown
45.86% % of shares held by all insiders
37.24% % of shares held by institutions
68.78% % of float held by institutions
19 Number of institutions holding shares
Anyone know who the main investors are now in Kromek ? I think about 35% held by small private investors ??
Thanks that is very helpful. The Phillips situation is very interesting….
This must be the new Philips CZT based imaging
Scanners that are using Kromek's CZT and one of the reasons they've increased their in house production furnace capacity recently.
Spectral Detector CT | CT Spectral Imaging | Philips Healthcare
https://www.philips.co.uk/healthcare/resources/landing/spectral-detector-ct
After Canons recent buy out of Canadian Redlen Tech and comments made about Kromek's under valuation, some might be interested to read/ watch this GE info on the new Star Guide which has set the bench mark on CZT medical colour imaging, reducing time to scan from 15mins to just 3 mins, and I assume other medical OEMs after developing now with Kromek's products.
Very impressive tech.
https://www.gehealthcare.com/products/molecular-imaging/starguide
Is it likely to also make the printed version of IC and if so when is it published? Readership copies c30,000 I think.
Am disappointed with managements lack of update on pathogen detection but hopefully means commercial discussions in progress but who knows !!??
Unlikely SDI would offer for this business. Whilst it is the type of company that they could conceivably acquire, to date they have tended to target small private firms for low multiples and that are very well run and typically family / founder run. They don't like to interfere with their companies too much a bit like Buffett, they trust them to do their thing which I don't think they could do here. Not a holder here, but watched for a couple of years and the price has slowly dwindled down and management seem to have a real lack of delivery, despite having some seemingly good products. Science group (SAG) may be more likely to target Kromek, as they don't mind a hostile takeover and would replace management.
Yes is positive. I would like to see directors take bigger stakes to increase my confidence…. disappointing that they don’t